Ropivacaine Hydrochloride recalls
Ropivacaine Hydrochloride products have been recalled 1 time, most recently on 14 May 2025. The recalling company is usually Amneal Pharmaceuticals. The most common reason is particulate matter.
Total recalls1since 2025
Last 12 months0reported
Class I1100% of total
Ongoing0latest 14 May 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 100%Class II 0 0%Class III 0 0%
Why ropivacaine hydrochloride is recalled
Companies
Product types
By year
All ropivacaine hydrochloride recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per (5mg/mL) recalledRopivacaine Hydrochloride | Amneal Pharmaceuticals | Particulate Matter | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.